Justin W Hicks1, Jun Parkes2, Junchao Tong2, Sylvain Houle2, Neil Vasdev3, Alan A Wilson4. 1. Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada, M5T 1R8; Institute of Medical Science, University of Toronto, Toronto, ON, Canada, M5S 1A8. 2. Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada, M5T 1R8. 3. Department of Radiology, Harvard Medical School and Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Boston, MA, USA, 02114. 4. Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada, M5T 1R8; Institute of Medical Science, University of Toronto, Toronto, ON, Canada, M5S 1A8. Electronic address: alan.wilson@camhpet.ca.
Abstract
INTRODUCTION: Monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH) are the two primary enzymes that regulate the tone of endocannabinoid signaling. Although new PET radiotracers have been discovered for imaging FAAH in vivo, no such radiotracer exists for imaging MAGL. Here we report the radiosynthesis of five candidate MAGL radiotracers and their ex vivo evaluations in mice and rats. METHODS: Candidate carbamate and urea MAGL inhibitors were radiolabeled at the carbonyl position by [(11)C]CO2 fixation. Radiotracers were administered (tail-vein injection) to rodents and brain uptake of radioactivity measured at early and late time points ex vivo. Specificity of uptake was explored by pretreatment with unlabeled inhibitors (2 mg/kg, ip) 30 min prior to radiotracer administration. RESULTS: All five candidate MAGL radiotracers were prepared in high specific activity (>65 GBq/μmol) and radiochemical purity (>98%). Moderate brain uptake (0.2-0.8 SUV) was observed for each candidate while pretreatment did not reduce uptake for four of the five tested. For two candidates ([(11)C]12 and [(11)C]14), high retention of radioactivity was observed in the blood (ca. 10 and 4 SUV at 40 min) which was blocked by pretreatment with unlabeled inhibitors. The most promising candidate, [(11)C]18, demonstrated moderate brain uptake (ca. 0.8 SUV) which showed circa 50% blockade by pretreatment with unlabeled 18. CONCLUSION: One putative and four reported potent and selective MAGL inhibitors have been radiolabeled via [(11)C]CO2 fixation as radiotracers for this enzyme. Despite the promising in vitro pharmacological profile, none of the five candidate radiotracers exhibited in vivo behavior suitable for PET neuroimaging.
INTRODUCTION:Monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH) are the two primary enzymes that regulate the tone of endocannabinoid signaling. Although new PET radiotracers have been discovered for imaging FAAH in vivo, no such radiotracer exists for imaging MAGL. Here we report the radiosynthesis of five candidate MAGL radiotracers and their ex vivo evaluations in mice and rats. METHODS: Candidate carbamate and ureaMAGL inhibitors were radiolabeled at the carbonyl position by [(11)C]CO2 fixation. Radiotracers were administered (tail-vein injection) to rodents and brain uptake of radioactivity measured at early and late time points ex vivo. Specificity of uptake was explored by pretreatment with unlabeled inhibitors (2 mg/kg, ip) 30 min prior to radiotracer administration. RESULTS: All five candidate MAGL radiotracers were prepared in high specific activity (>65 GBq/μmol) and radiochemical purity (>98%). Moderate brain uptake (0.2-0.8 SUV) was observed for each candidate while pretreatment did not reduce uptake for four of the five tested. For two candidates ([(11)C]12 and [(11)C]14), high retention of radioactivity was observed in the blood (ca. 10 and 4 SUV at 40 min) which was blocked by pretreatment with unlabeled inhibitors. The most promising candidate, [(11)C]18, demonstrated moderate brain uptake (ca. 0.8 SUV) which showed circa 50% blockade by pretreatment with unlabeled 18. CONCLUSION: One putative and four reported potent and selective MAGL inhibitors have been radiolabeled via [(11)C]CO2 fixation as radiotracers for this enzyme. Despite the promising in vitro pharmacological profile, none of the five candidate radiotracers exhibited in vivo behavior suitable for PET neuroimaging.
Authors: Oleg Sadovski; Justin W Hicks; Jun Parkes; Roger Raymond; José Nobrega; Sylvain Houle; Mariateresa Cipriano; Christopher J Fowler; Neil Vasdev; Alan A Wilson Journal: Bioorg Med Chem Date: 2013-05-07 Impact factor: 3.641
Authors: Benjamin H Rotstein; Steven H Liang; Jason P Holland; Thomas Lee Collier; Jacob M Hooker; Alan A Wilson; Neil Vasdev Journal: Chem Commun (Camb) Date: 2013-05-14 Impact factor: 6.222
Authors: T Suhara; Y Sudo; K Yoshida; Y Okubo; H Fukuda; T Obata; K Yoshikawa; K Suzuki; Y Sasaki Journal: Lancet Date: 1998-01-31 Impact factor: 79.321
Authors: Justin W Hicks; Jun Parkes; Oleg Sadovski; Junchao Tong; Sylvain Houle; Neil Vasdev; Alan A Wilson Journal: Nucl Med Biol Date: 2013-05-31 Impact factor: 2.408
Authors: Jonathan Z Long; Weiwei Li; Lamont Booker; James J Burston; Steven G Kinsey; Joel E Schlosburg; Franciso J Pavón; Antonia M Serrano; Dana E Selley; Loren H Parsons; Aron H Lichtman; Benjamin F Cravatt Journal: Nat Chem Biol Date: 2008-11-23 Impact factor: 15.040
Authors: Benjamin H Rotstein; Steven H Liang; Michael S Placzek; Jacob M Hooker; Antony D Gee; Frédéric Dollé; Alan A Wilson; Neil Vasdev Journal: Chem Soc Rev Date: 2016-08-22 Impact factor: 54.564
Authors: Isabelle Boileau; Pablo M Rusjan; Belinda Williams; Esmaeil Mansouri; Romina Mizrahi; Vincenzo De Luca; Douglas S Johnson; Alan A Wilson; Sylvain Houle; Stephen J Kish; Junchao Tong Journal: J Cereb Blood Flow Metab Date: 2015-06-17 Impact factor: 6.200
Authors: Ran Cheng; Masayuki Fujinaga; Jing Yang; Jian Rong; Ahmed Haider; Daisuke Ogasawara; Richard S Van; Tuo Shao; Zhen Chen; Xiaofei Zhang; Erick R Calderon Leon; Yiding Zhang; Wakana Mori; Katsushi Kumata; Tomoteru Yamasaki; Lin Xie; Shaofa Sun; Lu Wang; Chongzhao Ran; Yihan Shao; Benjamin Cravatt; Lee Josephson; Ming-Rong Zhang; Steven H Liang Journal: Acta Pharmacol Sin Date: 2022-05-05 Impact factor: 6.150
Authors: Ran Cheng; Wakana Mori; Longle Ma; Mireille Alhouayek; Akiko Hatori; Yiding Zhang; Daisuke Ogasawara; Gengyang Yuan; Zhen Chen; Xiaofei Zhang; Hang Shi; Tomoteru Yamasaki; Lin Xie; Katsushi Kumata; Masayuki Fujinaga; Yuji Nagai; Takafumi Minamimoto; Mona Svensson; Lu Wang; Yunfei Du; Mary Jo Ondrechen; Neil Vasdev; Benjamin F Cravatt; Christopher Fowler; Ming-Rong Zhang; Steven H Liang Journal: J Med Chem Date: 2018-03-09 Impact factor: 7.446
Authors: Andrew V Mossine; Allen F Brooks; Isaac M Jackson; Carole A Quesada; Phillip Sherman; Erin L Cole; David J Donnelly; Peter J H Scott; Xia Shao Journal: Bioconjug Chem Date: 2016-04-14 Impact factor: 4.774
Authors: Lu Hou; Jian Rong; Ahmed Haider; Daisuke Ogasawara; Cassis Varlow; Michael A Schafroth; Linjing Mu; Jiefeng Gan; Hao Xu; Christopher J Fowler; Ming-Rong Zhang; Neil Vasdev; Simon Ametamey; Benjamin F Cravatt; Lu Wang; Steven H Liang Journal: J Med Chem Date: 2020-12-30 Impact factor: 7.446